Call of the wild: Singapore businesses still keen on emerging markets
Overseas trips, trade fairs set to resume despite pandemic hiatus, global uncertainties
Annabeth Leow
IT WAS late 2019, and Singapore biotech startup Stratificare was all set to begin clinical studies in partnership with experts in Mexico, for a test that might prove able to predict severe cases of dengue.
The tie-up arose from Stratificare's participation in a business delegation accompanying Prime Minister Lee Hsien Loong on his official visit to that country.
But the novel coronavirus hit – and that made it “very difficult for us to run any clinical study there”, Stratificare chief executive Anthony Chua told The Business Times.
TRENDING NOW
Hell hath no fury like a man scorned: CEO’s S$468,000 suit against ex fails after relationship sours
Floods compound Philippine growth woes from public-works scandal
Singdollar hits 10-month high against ringgit as investors take refuge in traditional safe haven
How Asia’s next generation is rewriting legacy through entrepreneurship